Mayne Pharma Group Ltd. | Mutual Funds
Mutual Funds that own Mayne Pharma Group Ltd.
Vanguard Total International Stock Index Fund
21,227,422
1.35%
0
0.01%
07/31/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
17,333,427
1.1%
17,333,427
0%
03/31/2018
Vanguard Australian Shares Index Fund
9,989,758
0.64%
146,759
0.09%
07/31/2018
Government Pension Fund - Global (The)
8,501,663
0.54%
-6,213,437
0%
12/31/2017
Vanguard Developed Markets Index Fund
8,419,859
0.54%
0
0.01%
07/31/2018
iShares MSCI EAFE Small Cap ETF
6,625,579
0.42%
0
0.05%
09/06/2018
DFA Asia Pacific Small Company Series
6,571,574
0.42%
0
0.28%
01/31/2018
DFA International Small Cap Value Portfolio
6,497,735
0.41%
1,175,723
0.03%
04/30/2018
iShares Core MSCI EAFE ETF
6,336,337
0.4%
0
0.01%
09/06/2018
Mirrabooka Investments Ltd.
4,437,784
0.28%
323,340
1.23%
06/30/2017
| Address |
1538 Main North Road
Salisbury South Australia (SA) 5106
Australia
|
|
Employees
|
- |
| Website |
http://www.maynepharma.com |
| Updated |
07/08/2019 |
| Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. |
